Oncolys BioPharma Inc.
TSE:4588.T
Overview | Financials
Company Name | Oncolys BioPharma Inc. |
Symbol | 4588.T |
Currency | JPY |
Price | 666 |
Market Cap | 16,049,116,818 |
Dividend Yield | 0% |
52-week-range | 420 - 798 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yasuo Urata M.Sc. |
Website | https://www.oncolys.com |
An error occurred while fetching data.
About Oncolys BioPharma Inc.
Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States. Its product pipeline includes Telomelysin (OBP-301), an oncolytic adenovirus that is in phase II clinical trial for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD